Stay updated on APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.

Latest updates to the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the previous notices about funding lapses and operating status were removed. No study data or eligibility information were modified.SummaryDifference0.3%

- Check21 days agoChange DetectedA government funding status notice has been added to the page, indicating that information may not be up to date and directing users to official sources for updates. The page also shows a revision update to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedShow glossary added to help interpret terms on the study page. The page now shows the latest QC update status and the new Revision: v3.4.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed, reflecting a minor version update; core study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section was updated with added sites across the US, Australia, Belgium, Canada, France, Germany, Japan and other regions, and some sites were removed. The study record revision was updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check92 days agoChange DetectedPublications are now described as automatically populated from PubMed and may not all be about the study. The page revision line shows Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.